Literature DB >> 8077889

Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver diseases.

H Bell1, A Skinningsrud, N Raknerud, K Try.   

Abstract

OBJECTIVES: To compare serum ferritin concentration and transferrin saturation in patients with alcoholic and non-alcoholic chronic liver diseases.
DESIGN: Consecutive patients with liver diseases.
SETTING: The department of internal medicine in a teaching hospital.
SUBJECTS: Three hundred and twelve patients with different liver diseases consecutively admitted between 1987 and 1992.
INTERVENTIONS: None. MAIN OUTCOME MEASURES: Fasting serum iron, transferrin and ferritin.
RESULTS: Serum ferritin was increased above 200 micrograms L-1 in all 18 patients with haemochromatosis (range 310-6500 micrograms L-1), in 64 of 111 alcoholics (58%) and in 30 of 137 (22%) with chronic non-alcoholic liver diseases (P < 0.01). Twelve of 111 alcoholics (11%) had serum ferritin above 1000 micrograms L-1 compared with one of 137 (0.7%) with chronic non-alcoholic liver diseases. In 13 alcoholics who abstained after admission, serum ferritin decreased from 1483 micrograms L1 +/- 1134 to 388 micrograms L-1 +/- 237 (P < 0.001) after 1 1/2 to 6 weeks. The transferrin saturation was increased above 62% in 13 of 18 patients (72%) with haemochromatosis, in 16 of 105 alcoholics (15.2%) and in three of 132 (2.3%) with chronic non-alcoholic liver disease (P < 0.01).
CONCLUSION: Serum ferritin is more frequently elevated in abusing patients with alcoholic liver disease than in patients with other chronic liver diseases such as autoimmune liver diseases and hepatitis C. Because serum ferritin decreases rapidly during abstinence, the measurement of ferritin for the detection of haemochromatosis in patients abusing alcohol should be postponed until the patients are abstaining. Most of the patients with increased serum ferritin have normal transferrin saturation values which can be used to separate them from haemochromatosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077889     DOI: 10.1111/j.1365-2796.1994.tb00802.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  26 in total

1.  Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Kris V Kowdley; Patricia Belt; Laura A Wilson; Matthew M Yeh; Brent A Neuschwander-Tetri; Naga Chalasani; Arun J Sanyal; James E Nelson
Journal:  Hepatology       Date:  2011-12-06       Impact factor: 17.425

2.  The diversity of liver diseases among outpatient referrals for an elevated serum ferritin.

Authors:  Karen Wong; Paul C Adams
Journal:  Can J Gastroenterol       Date:  2006-07       Impact factor: 3.522

3.  Post-test probability that men in the community with raised plasma ferritin concentrations are hazardous drinkers.

Authors:  H G Peach; N E Bath
Journal:  J Clin Pathol       Date:  1999-11       Impact factor: 3.411

Review 4.  Is the iron regulatory hormone hepcidin a risk factor for alcoholic liver disease?

Authors:  Duygu Dee Harrison-Findik
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

5.  Cutoff values of serum ferritin and TIBC saturation for the evaluation of gastrointestinal neoplasms in adult anemic patients.

Authors:  Mark Hong Lee; Eugene Park; Jongchan Lee; So Young Kim; Sung Yong Kim; Sun Young Lee; Yo Han Cho; So Young Yoon
Journal:  Int J Hematol       Date:  2012-06-28       Impact factor: 2.490

6.  Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screening.

Authors:  James C Barton; Ronald T Acton; Catherine Leiendecker-Foster; Laura Lovato; Paul C Adams; John H Eckfeldt; Christine E McLaren; Jacob A Reiss; Gordon D McLaren; David M Reboussin; Victor R Gordeuk; Mark R Speechley; Richard D Press; Fitzroy W Dawkins
Journal:  Am J Hematol       Date:  2008-02       Impact factor: 10.047

7.  The assessment of serum soluble transferrin receptor in alcoholics.

Authors:  Bogdan Cylwik; Lech Chrostek; Marta Daniluk; Alicja Koput; Maciej Szmitkowski
Journal:  Clin Exp Med       Date:  2010-03       Impact factor: 3.984

8.  Serum ferritin levels lack diagnostic accuracy for liver fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Paul Angulo; Jacob George; Christopher P Day; Ester Vanni; Lee Russell; Anna C De la Cruz; Hammad Liaquat; Lavinia Mezzabotta; Eun Lee; Elisabetta Bugianesi
Journal:  Clin Gastroenterol Hepatol       Date:  2013-12-14       Impact factor: 11.382

9.  Iron homeostasis and H63D mutations in alcoholics with and without liver disease.

Authors:  Mariana Verdelho Machado; Paula Ravasco; Alexandra Martins; Maria Rosário Almeida; Maria Ermelinda Camilo; Helena Cortez-Pinto
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

10.  Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells.

Authors:  Richard G Ruddell; Diem Hoang-Le; Joanne M Barwood; Paul S Rutherford; Terrance J Piva; Dianne J Watters; Paolo Santambrogio; Paolo Arosio; Grant A Ramm
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.